Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Carcinoma, Renal Cell 13Sarcoma 10Neoplasms 10Breast Neoplasms 8Neoplasm Metastasis 7Carcinoma, Non-Small-Cell Lung 5Ovarian Neoplasms 3Colorectal Neoplasms 3Advanced Cancers 3Thyroid Neoplasms 2Solid Tumors 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Melanoma 2Lung Neoplasms 2Liver Neoplasms 2Kidney Neoplasms 2Head and Neck Neoplasms 2Wilms Tumor 1Unspecified Adult Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor - Protocol Specific 1Thyroid Cancer, Papillary 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumours 1Solid Neoplasm 1Recurrence 1Osteosarcoma 1Optic Nerve Glioma 1Neuroblastoma 1Lymphoma 1

Interventions

Temozolomide 48Radiotherapy 26Radiation 13Chemotherapy, Adjuvant 9O(6)-benzylguanine 8Irinotecan 8Carmustine 8Surgical Procedures, Operative 7Magnetic Resonance Spectroscopy 6Erlotinib Hydrochloride 6motexafin gadolinium 5Radiotherapy, Intensity-Modulated 5Imatinib Mesylate 5sargramostim 4Radiotherapy, Conformal 4Hydroxyurea 4Gene Expression Profiling 4lonafarnib 3Radiosurgery 3Immunohistochemistry 3Genetic Therapy 3Filgrastim 3Drug Therapy 32,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 3vandetanib 2tipifarnib 2temsirolimus 2cediranib 2aldesleukin 2Vorinostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Gliosarcoma × pazopanib × Clear all
NCT03275558 2018-07-19

Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma

Center Trials & Treatment

Phase 1 Withdrawn
CNSSarcoma

Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡